Breaking News, Financial News

ICON 3Q

ICON revenues dropped, but earnings were strong.

ICON 3Q09

3Q Revenues: $220 million (-2%)

3Q Earnings: $24 million (+12%)

YTD Revenues: $660 million (+2%)

YTD Earnings: $63 million (+11%)

Comments: Chief executive officer Peter Gray remarked, “While higher than normal cancellations held back net business awards, the levels of business opportunity continue to be strong and we remain optimistic for the future.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters